Experiment 67330

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationLILIENFELD,S: PARYS,W:. (2000). GALANTAMINE: ADDITIONAL BENEFITS TO PATIENTS WITH ALZHEIMER'S DISEASE.. 11(1)
Amount utilized
Compound isolated
DiseaseA META-ANALYSIS STUDY OF GALANTAMINE ON COGNITIVE FUNCTIONS IN ALZHEIMER'S PATIENTS. RESULTS SHOWED THAT COGNITIVE AND DAILY FUNCTIONS ARE MAINTAINED AND THAT IT WAS WELL TOLERATED.
Dose amountVAR
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES